Literature DB >> 17369846

CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.

T Aleksic1, M Bechtel, D Krndija, G von Wichert, B Knobel, K Giehl, T M Gress, P Michl.   

Abstract

Recently, we identified the homeodomain transcription factor CUTL1 as important mediator of cell migration and tumor invasion downstream of transforming growth factor beta (TGFbeta). The molecular mechanisms and effectors mediating the pro-migratory and pro-invasive phenotype induced by CUTL1 have not been elucidated so far. Therefore, the aim of this study was to identify signaling pathways downstream of CUTL1 which are responsible for its effects on tumor cell migration. We found that the reduced motility seen after knock down of CUTL1 by RNA interference is accompanied by a delay in tumor cell spreading. This spreading defect is paralleled by a marked reduction of Src protein levels. We show that CUTL1 leads to Src protein stabilization and activation of Src-regulated downstream signaling molecules such as RhoA, Rac1, Cdc42 and ROCK. In addition, we demonstrate that CUTL1 decreases proteasome-mediated Src protein degradation, possibly via transcriptionally upregulating C-terminal Src kinase (Csk). Based on experiments using Src knockout cells (SYF), we present evidence that Src plays a crucial role in CUTL1-induced tumor cell migration. In conclusion, our findings linking the pro-invasive transcription factor CUTL1 and the Src pathway provide important new insights in the molecular effector pathways mediating CUTL-induced migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369846     DOI: 10.1038/sj.onc.1210398

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Authors:  Stefanie Ripka; Jan Riedel; Albrecht Neesse; Heidi Griesmann; Malte Buchholz; Volker Ellenrieder; Franz Moeller; Peter Barth; Thomas M Gress; Patrick Michl
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

2.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

3.  Asynchronous expression of the homeodomain protein CUX1 in Sertoli cells and spermatids during spermatogenesis in mice.

Authors:  Melissa R Kroll; Engela S Viss; Jonathan Lamb; Joy Horstman; Alexander Powell; Andrea Van Wyk; Kaarlo Hinkkala; Traci Hoogland; Matthew Schippers; Stephen Shannon; Carol G Carlton; Madhulika Sharma; Aaron Taylor; Gregory B Vanden Heuvel; Tony N Jelsma
Journal:  Biol Reprod       Date:  2010-10-27       Impact factor: 4.285

4.  The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion.

Authors:  Valérie Kedinger; Alain Nepveu
Journal:  Cell Adh Migr       Date:  2010-07-04       Impact factor: 3.405

5.  Ectopic expression of Cux1 is associated with reduced p27 expression and increased apoptosis during late stage cyst progression upon inactivation of Pkd1 in collecting ducts.

Authors:  Binu M Paul; Dianne Vassmer; Aaron Taylor; Lynn Magenheimer; Carol G Carlton; Klaus B Piontek; Gregory G Germino; Gregory B Vanden Heuvel
Journal:  Dev Dyn       Date:  2011-04-04       Impact factor: 3.780

Review 6.  Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes.

Authors:  Ryan F Leung; Ankita M George; Enola M Roussel; Maree C Faux; Jeffrey T Wigle; David D Eisenstat
Journal:  Front Neurosci       Date:  2022-04-25       Impact factor: 5.152

7.  p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.

Authors:  Valerie Kedinger; Laurent Sansregret; Ryoko Harada; Charles Vadnais; Chantal Cadieux; Kelly Fathers; Morag Park; Alain Nepveu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 8.  CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers.

Authors:  Zubaidah M Ramdzan; Alain Nepveu
Journal:  Nat Rev Cancer       Date:  2014-09-05       Impact factor: 60.716

9.  Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array.

Authors:  Charles Vadnais; Arif A Awan; Ryoko Harada; Pier-Luc Clermont; Lam Leduy; Ginette Bérubé; Alain Nepveu
Journal:  BMC Genomics       Date:  2013-04-16       Impact factor: 3.969

Review 10.  CUX1, A Controversial Player in Tumor Development.

Authors:  Ning Liu; Qiliang Sun; Long Wan; Xuan Wang; Yu Feng; Judong Luo; Hailong Wu
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.